Integrity Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Buy
3,095
+231
+8% +$82.3K 0.65% 29
2025
Q4
$937K Sell
2,864
-4,085
-59% -$1.3M 0.64% 31
2025
Q3
$1.95M Buy
6,949
+3,199
+85% +$928K 0.7% 21
2025
Q2
$1.05M Sell
3,750
-151
-4% -$42.8K 0.73% 23
2025
Q1
$1.22M Buy
3,901
+151
+4% +$44.6K 0.89% 17
2024
Q4
$977K Buy
+3,750
New +$1.11M 0.71% 21

Other funds holding AMGN

Integrity Wealth Advisors's AMGN Position: Q1 2026 in Review

Integrity Wealth Advisors increased its Amgen (AMGN) stake by 8.1% in Q1 2026, buying an estimated $82.3K and bringing the position to 3,095 shares worth $1.09M. The position accounts for 0.65% of the portfolio, ranked #29.

Integrity Wealth Advisors first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.95M in Q3 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Integrity Wealth Advisors held 3,095 shares of Amgen worth $1.09M as of Q1 2026.
  • Integrity Wealth Advisors bought 231 Amgen shares in Q1 2026, an estimated $82.3K.
  • Amgen made up 0.65% of Integrity Wealth Advisors's portfolio in Q1 2026, its #29 holding.
  • Integrity Wealth Advisors first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • Integrity Wealth Advisors's Amgen position peaked at $1.95M in Q3 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Integrity Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.